We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.4%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$301B
AUM Growth
+$5.54B
Cap. Flow
-$7B
Cap. Flow %
-2.32%
Top 10 Hldgs %
14.22%
Holding
9,997
New
1,505
Increased
3,920
Reduced
3,392
Closed
881

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$937M
2
UBS icon
UBS Group
UBS
+$511M
3
MSFT icon
Microsoft
MSFT
+$402M
4
BIDU icon
Baidu
BIDU
+$338M
5
AAPL icon
Apple
AAPL
+$331M

Sector Composition

Rank Sector Weight
1 Technology 11.08%
2 Consumer Discretionary 6.75%
3 Financials 6.3%
4 Healthcare 5.83%
5 Industrials 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELVN icon
7651
Enliven Therapeutics
ELVN
$4.37B
$14K ﹤0.01%
410
+131
+47% +$6.66K
FFEB icon
7652
FT Vest US Equity Buffer ETF February
FFEB
$1.4B
$14K ﹤0.01%
+413
New +$13.9K
GALT icon
7653
Galectin Therapeutics
GALT
$196M
$14K ﹤0.01%
6,454
-17,114
-73% -$38.4K
GCBC icon
7654
Greene County Bancorp
GCBC
$590M
$14K ﹤0.01%
1,098
-1,590
-59% -$20.1K
IRON icon
7655
Disc Medicine
IRON
$2.99B
$14K ﹤0.01%
+34
New +$15.2K
KOSS icon
7656
Koss Corp
KOSS
$35M
$14K ﹤0.01%
603
-4,227
-88% -$74.7K
MFIN icon
7657
Medallion Financial
MFIN
$251M
$14K ﹤0.01%
1,991
+516
+35% +$3.36K
NEXT icon
7658
NextDecade
NEXT
$1.74B
$14K ﹤0.01%
5,142
+623
+14% +$1.39K
PPTY
7659
US Diversified Real Estate ETF
PPTY
$25.8M
$14K ﹤0.01%
+443
New +$13.4K
SGA icon
7660
Saga Communications
SGA
$58.9M
$14K ﹤0.01%
633
+87
+16% +$1.93K
SRS icon
7661
ProShares UltraShort Real Estate
SRS
$15.2M
$14K ﹤0.01%
165
-191
-54% -$17.9K
UTES icon
7662
Virtus Reaves Utilities ETF
UTES
$1.32B
$14K ﹤0.01%
342
-2,023
-86% -$81K
VVOS icon
7663
Vivos Therapeutics
VVOS
$6.42M
$14K ﹤0.01%
+85
New +$15.2K
WBIY icon
7664
WBI Power Factor High Dividend ETF
WBIY
$64.4M
$14K ﹤0.01%
540
-2,807
-84% -$70.9K
WLDR icon
7665
Simplify Affinity World Leaders Equity ETF
WLDR
$94.4M
$14K ﹤0.01%
527
-173
-25% -$4.29K
ENFY
7666
DELISTED
Enlightify Inc
ENFY
$14K ﹤0.01%
2,604
-2,353
-47% -$12.4K
BIOL
7667
DELISTED
Biolase, Inc.
BIOL
$14K ﹤0.01%
+7
New +$17.2K
DALT
7668
DELISTED
Anfield Diversified Alternatives ETF
DALT
$14K ﹤0.01%
1,440
-1,575
-52% -$15.7K
MTBL
7669
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$14K ﹤0.01%
16,000
+4,970
+45% +$3.9K
DHCAU
7670
DELISTED
DHC Acquisition Corp. Unit
DHCAU
$14K ﹤0.01%
+1,375
New +$13.7K
ALTUU
7671
DELISTED
Altitude Acquisition Corp Unit
ALTUU
$14K ﹤0.01%
1,300
+327
+34% +$3.75K
VRPX
7672
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$14K ﹤0.01%
+12
New +$16.1K
LTRPA
7673
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$14K ﹤0.01%
2,266
-15,136
-87% -$81.8K
DOMA
7674
DELISTED
Doma Holdings, Inc.
DOMA
$14K ﹤0.01%
+56
New +$14.2K
RXDX
7675
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$14K ﹤0.01%
+776
New +$16K

Similar funds

UBS Group's Q1 2021 Portfolio in Review

As of Q1 2021, UBS Group held 9,997 positions worth $301B, up 1.9% from $296B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q1 2021 filing shows 1,505 new, 3,920 increased, 3,392 reduced and 881 closed positions. Its largest new stake was Ferguson: 1,602,252 shares worth $192M. The largest sale was Stellantis, an estimated $937M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

  • UBS Group's largest Q1 2021 buy was Ferguson: 1,602,252 shares worth $192M.
  • UBS Group added most to Alibaba in Q1 2021, an estimated $2.76B increase.
  • UBS Group's biggest Q1 2021 reduction was Stellantis, cutting an estimated $937M.
  • UBS Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $77.2M.
  • UBS Group's ten largest holdings make up 14% of its $301B portfolio in Q1 2021.
  • UBS Group opened 1,505 new positions and closed 881 in Q1 2021.
  • UBS Group's portfolio value rose 1.9% quarter-over-quarter to $301B.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.